KPC Pharmaceuticals

KPC Pharmaceuticals Interest Coverage

The Interest Coverage Ratio of KPC Pharmaceuticals (600422.SS) as of Nov 4, 2026 is 107.28. In the previous year, Interest Coverage Ratio was 108.96 — a change of -1.54% (lower).

Interest Coverage

107.28

YoY

-1.54%

Last updated:

Interest Coverage Ratio of KPC Pharmaceuticals is 2024 107.28 . Interest Coverage Ratio of KPC Pharmaceuticals was 2023 108.96 . It decreases by -1.54% lower compared to the previous year.

The KPC Pharmaceuticals Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
10.90 CNY
Jan 1, 2018
10.26 CNY
Jan 1, 2019
68.78 CNY
Jan 1, 2020
40.06 CNY
Jan 1, 2021
88.60 CNY
Jan 1, 2022
42.19 CNY
Jan 1, 2023
108.96 CNY
Jan 1, 2024
107.28 CNY
The KPC Pharmaceuticals Interest Coverage history
YEARInterest CoverageYoY
107.28-1.54%
108.96+158.22%
42.19-52.38%
88.60+121.15%
40.06-41.75%
68.78+570.08%
10.26-5.81%
10.90-62.71%
29.23-22.76%
37.84+52.38%
24.83—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KPC Pharmaceuticals Stock analysis

What does KPC Pharmaceuticals do? KPC Pharmaceuticals, Inc. generates revenue through the research, development, manufacturing, and international marketing of its diverse drug portfolio. The company sells natural herbal medicines, traditional Chinese medicines, and chemical synthetic drugs, including central nervous system drugs, cardiovascular and cerebrovascular drugs, anti-parasitic drugs, anti-microbial drugs, anti-gout drugs, hormones and endocrine drugs, hemorrhoids medicines, and anti-inflammatory drugs. Its main customers are healthcare providers, hospitals, and pharmaceutical distributors globally. The firm also produces health products and offers medical services as additional revenue streams. The company's product segments are defined by therapeutic categories such as central nervous system treatments, cardiovascular care, and anti-inflammatory solutions. These products target both domestic and international markets, with a focus on traditional Chinese medicine and natural herbal formulations. Sales are driven by wholesale distribution networks and direct commercial partnerships in the pharmaceutical industry. KPC Pharmaceuticals' revenue model combines product sales from its core drug lines with supplementary health product offerings and medical service provision. The business leverages its manufacturing capabilities in Kunming, Yunnan to serve global markets, with a strong emphasis on traditional Chinese medicine and natural herbal medicine segments. The firm's international marketing efforts support its presence in multiple regions. KPC Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KPC Pharmaceuticals stock

Interest Coverage Ratio of KPC Pharmaceuticals is 107.28 in 2024.

Interest Coverage Ratio of KPC Pharmaceuticals changed from 108.96 to 107.28, representing a -1.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio KPC Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's KPC Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — KPC Pharmaceuticals

All Key Metrics — KPC Pharmaceuticals